Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Cardiology · Mitral Stenosis

Diagnosis & Your Echocardiogram Report

At a Glance

A mitral stenosis echocardiogram measures the valve opening, pressure gradient, and valve structure. The results must be interpreted with heart rate, rhythm, blood flow, symptoms, and—when a procedure is considered—Wilkins score and clot or leakage findings.

When preparing to discuss your heart health, it is reassuring to know exactly what tests you are having and why. To understand what is happening with your mitral valve, doctors rely on a specialized ultrasound called an echocardiogram. Because mitral stenosis is a mechanical obstruction, this “echo” acts like a digital ruler, measuring the size of the opening and the pressure of the blood trying to get through it [1][2].

The Mitral Valve Area (MVA)

The most important number on your report is the Mitral Valve Area (MVA). This tells you exactly how much space is left for blood to flow through the “door.”

  • Planimetry: This is considered a reference method for measuring the valve. Instead of using math to guess the size, the technician “draws” a circle around the actual opening on the screen [1][3]. 3D Echocardiography is often preferred here because it allows doctors to see the valve from multiple angles, ensuring they are measuring the narrowest point [4][5].
  • The Thresholds: A normal valve area is 4 to 6 cm². In modern cardiology, an MVA of 1.5 cm² or less is usually used to describe clinically significant rheumatic mitral stenosis [6][7]. Measurements around 1.0 cm² or less indicate severe disease, though these numbers must be interpreted alongside your gradient, flow, and symptoms [6].

Understanding ‘Load Dependency’

Your report will also list the Mean Transmitral Gradient and Pressure Half-Time (PHT). These numbers are “load-dependent,” meaning they can change based on what your body is doing at the moment of the test [2][8].

  • Mean Gradient: This measures the average pressure difference between the chambers. While a gradient of 10 mmHg or higher often indicates severe disease, this number can be misleading. If your heart is beating very fast (tachycardia) or if you are exercising, the gradient will go up. Conversely, if your heart is weak and not pumping much blood, the gradient might look low even if the valve is dangerously narrow [9][10].
  • Rhythm Matters: If you have atrial fibrillation (Afib), your heart rate is irregular. Because the “load” changes with every beat, the technician must average 5 to 8 different heartbeats to get an accurate number [10][11].

The Wilkins Score: Planning a Procedure

If your doctor is considering a procedure to open the valve—specifically a balloon procedure called PMBC—they will calculate a Wilkins Score [12]. This score looks at four specific features of your valve:

  1. Leaflet Mobility: How well the “doors” can still move.
  2. Leaflet Thickening: How much scar tissue is present.
  3. Subvalvular Thickening: How stiff the “strings” (chordae) holding the valve are.
  4. Calcification: How much hard mineral buildup is on the valve [12][1].

Each category is scored from 1 to 4. A total score of 8 or less generally means the valve has more favorable anatomy for being stretched open with a balloon, but it does not guarantee PMBC is appropriate; your doctor must also check for contraindications like a left-atrial clot or significant regurgitation. A score higher than 12 often means the valve is less favorable and may require surgery instead [13][14].

When the Report Doesn’t Match the Patient

Sometimes, a patient feels extremely short of breath, but their resting echo report only shows “moderate” disease. In these cases, doctors use two other tools:

  • Stress Echocardiography: You may be asked to walk on a treadmill while having an echo. This shows the doctor how the pressure gradient changes when your heart is working hard. If the pressure spikes significantly during exercise, it supports the conclusion that the valve is causing your symptoms, though specialist interpretation is needed [1][15].
  • Transesophageal Echo (TEE): If the standard echo (on your chest) isn’t clear enough, a small probe is passed down the esophagus (the food pipe). This provides a high-definition view from right behind the heart, which is essential for checking for blood clots before a procedure [12][16].

Common questions in this guide

What does the mitral valve area on my echocardiogram mean?
The mitral valve area (MVA) is the size of the opening available for blood to pass through. A normal area is about 4 to 6 cm²; 1.5 cm² or less commonly indicates clinically significant rheumatic mitral stenosis, while about 1.0 cm² or less suggests severe narrowing. Your clinician interprets this number with the pressure gradient, blood flow, and symptoms.
Can my mean gradient look different depending on my heart rate?
Yes. A faster heartbeat or exercise can raise the mean pressure gradient, while a weak heart that moves less blood can produce a lower gradient even when the valve is very narrow. The result should be considered with the valve area, blood flow, symptoms, and test conditions.
What if I have atrial fibrillation during the echocardiogram?
Atrial fibrillation makes the heart’s filling and pumping vary from beat to beat, which can make a single measurement unreliable. The technician usually averages measurements from about 5 to 8 beats to estimate the mean gradient more accurately.
How is the Wilkins score used before balloon treatment?
The Wilkins score rates leaflet movement, leaflet thickening, thickening beneath the valve, and calcification, with each feature scored from 1 to 4. A total of 8 or less generally suggests anatomy that is more favorable for percutaneous mitral balloon commissurotomy, while a score above 12 is often less favorable. The score does not decide treatment by itself; doctors also check for a left-atrial clot and a significant leak through the valve.
Why would I need a stress echocardiogram if my resting results are moderate?
A stress echocardiogram shows how the pressure across the mitral valve changes when your heart works harder. A marked rise during exercise can support the conclusion that the valve is contributing to shortness of breath when the resting study does not fully explain your symptoms.
What is a transesophageal echocardiogram used for in mitral stenosis?
A transesophageal echocardiogram, or TEE, uses a small probe in the esophagus to obtain a clearer view of the heart from behind. It can help assess the valve and look for a blood clot in the left atrial appendage before a procedure.
Does 3D echocardiography improve mitral valve area measurement?
Planimetry traces the actual valve opening, and 3D echocardiography lets clinicians view it from multiple angles to better identify the narrowest point. Whether 2D or 3D is most useful depends on the image quality and clinical situation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my Mitral Valve Area (MVA) measured using 2D or 3D planimetry, and how confident are you in that measurement?
  2. 2.Since my mean gradient can change based on my heart rate, was it measured at a time when my heart rate was resting or elevated?
  3. 3.What was my Wilkins Score, and which of the four categories (mobility, thickening, calcification, or subvalvular disease) had the highest score?
  4. 4.If my resting numbers look 'moderate' but I feel very short of breath, should we consider a stress echocardiogram to see how the valve behaves during exercise?
  5. 5.Did the imaging show any signs of a blood clot in the left atrial appendage, and do I need a Transesophageal Echo (TEE) for a closer look?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Advances in Rheumatic Mitral Stenosis: Echocardiographic, Pathophysiologic, and Hemodynamic Considerations.

    Silbiger JJ

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2021; (34(7)):709-722.e1 doi:10.1016/j.echo.2021.02.015.

    PMID: 33652082
  2. 2

    Mitral Stenosis in the Multimodality Imaging Era: Pitfalls, Stress Echocardiography, and Integrated Therapeutic Assessment.

    Pala B, Piscione M, Gaudio D, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(14)) doi:10.3390/diagnostics16142285.

    PMID: 42510148
  3. 3

    Echocardiographic 3D-guided 2D planimetry in quantifying left-sided valvular heart disease.

    Argulian E, Seetharam K

    Echocardiography (Mount Kisco, N.Y.) 2018; (35(5)):695-706 doi:10.1111/echo.13828.

    PMID: 29420834
  4. 4

    Advancing Assessment of Degenerative Mitral Stenosis: The Role of Three-Dimensional Echocardiography.

    Menzà G, Navazio A

    Cardiology 2026; 1-14 doi:10.1159/000553579.

    PMID: 42647441
  5. 5

    Three-dimensional transesophageal echocardiography measurement of mitral valve area in patients with rheumatic mitral stenosis: multiplanar reconstruction or 3D direct planimetry?

    Zhong X, Chen W, Shi Z, et al.

    The international journal of cardiovascular imaging 2021; (37(1)):99-107 doi:10.1007/s10554-020-01950-1.

    PMID: 32719991
  6. 6

    A Novel Assessment Using Projected Transmitral Gradient Improves Diagnostic Yield of Doppler Hemodynamics in Rheumatic and Calcific Mitral Stenosis.

    Kato N, Pislaru SV, Padang R, et al.

    JACC. Cardiovascular imaging 2021; (14(3)):559-570 doi:10.1016/j.jcmg.2020.12.013.

    PMID: 33582068
  7. 7

    Validation of Yeo's index in assessing severity of rheumatic mitral stenosis in mixed valve lesions.

    Leow R, Li TY, Kong WKF, et al.

    International journal of cardiology. Heart & vasculature 2024; (53()):101447 doi:10.1016/j.ijcha.2024.101447.

    PMID: 38979528
  8. 8

    Impact of Net Atrioventricular Compliance on Mitral Valve Area Assessment-A Perspective Considering Three-Dimensional Mitral Valve Area by Transesophageal Echocardiography.

    Li T, Leow R, Chan MW, et al.

    Diagnostics (Basel, Switzerland) 2024; (14(15)) doi:10.3390/diagnostics14151595.

    PMID: 39125471
  9. 9

    Low-Gradient Severe Mitral Stenosis: Hemodynamic Profiles, Clinical Characteristics, and Outcomes.

    El Sabbagh A, Reddy YNV, Barros-Gomes S, et al.

    Journal of the American Heart Association 2019; (8(5)):e010736 doi:10.1161/JAHA.118.010736.

    PMID: 30793648
  10. 10

    The impact of cardiac rhythm on the mitral valve area and gradient in patients with mitral stenosis.

    Arı H, Arı S, Karakuş A, et al.

    Anatolian journal of cardiology 2017; (18(2)):90-98 doi:10.14744/AnatolJCardiol.2017.7614.

    PMID: 28554987
  11. 11

    Clinical and Hemodynamic Factors Associated with Low Gradient Severe Rheumatic Mitral Stenosis.

    Soesanto AM, Roeswita D, Atmosudigdo IS, et al.

    The International journal of angiology : official publication of the International College of Angiology, Inc 2023; (32(1)):43-47 doi:10.1055/s-0042-1751231.

    PMID: 36727152
  12. 12

    Echocardiography Assessment of Rheumatic Heart Disease: Implications for Percutaneous Balloon Mitral Valvuloplasty.

    Mohamed Ali A, Packer EJS, Omdal TR, et al.

    Current problems in cardiology 2023; (48(12)):102021 doi:10.1016/j.cpcardiol.2023.102021.

    PMID: 37544629
  13. 13

    Novel Prognostic Score for Immediate and Late Success After Percutaneous Mitral Balloon Commissurotomy in Patients With Mitral Stenosis.

    Prota-Filho LEB, Meneguz-Moreno RA, Queiroz CCV, et al.

    The Journal of invasive cardiology 2020; (32(6)):211-217.

    PMID: 32269178
  14. 14

    Very Long Term Follow-Up After Percutaneous Balloon Mitral Valvuloplasty.

    Meneguz-Moreno RA, Costa JR, Gomes NL, et al.

    JACC. Cardiovascular interventions 2018; (11(19)):1945-1952 doi:10.1016/j.jcin.2018.05.039.

    PMID: 30077684
  15. 15

    Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations.

    Galusko V, Ionescu A, Edwards A, et al.

    European heart journal. Quality of care & clinical outcomes 2022; (8(6)):602-618 doi:10.1093/ehjqcco/qcab083.

    PMID: 34878131
  16. 16

    Characteristics and immediate outcomes of patients who underwent percutaneous balloon mitral valvuloplasty at the Jakaya Kikwete Cardiac Institute, Tanzania.

    Mutagaywa RK, Cramer MJ, Chillo P, et al.

    Cardiovascular journal of Africa 2024; (35(1)):16-26 doi:10.5830/CVJA-2022-068.

    PMID: 36745007

This page is for informational purposes only and does not constitute medical advice. Your cardiologist should interpret your echocardiogram measurements, symptoms, and procedure options together.

Get notified when new evidence is published on mitral valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.